GINA 2024 Asthma Update: Revised Recommendations on …
Jun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
GOLD COPD Report 2025: Key Spirometry and Drug Updates
Nov 22, 2024 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, along with a pocket guide to the report and the “2025 …
Air Embolism | Diagnosis & Disease Information - Pulmonology …
Apr 29, 2024 · Air embolism is a rare but potentially life-threatening medical condition that occurs when air bubbles enter the bloodstream, which can block the flow of blood to vital organs. 1,2 When an air bubble enters a vein, it is referred to as a venous air embolism, while an air bubble entering an artery is an arterial air embolism. 1 Epidemiology and Etiology of Air Embolism
Restrictive Lung Diseases | Diagnosis & Disease Information
May 29, 2024 · Restrictive lung diseases are respiratory disorders marked by diminished lung capacity stemming from a wide range of underlying factors, including changes in lung parenchyma or conditions that affect the pleura, chest wall, or neuromuscular system. 1 Restrictive lung diseases can be classified as pulmonary parenchyma diseases (intrinsic causes) or extrapulmonary diseases (extrinsic causes ...
2024 GOLD Report Reflects New Research on COPD Management
Dec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report author and science committee chair for the Global ...
Tezepelumab Gets Breakthrough Therapy Status for COPD Tx
Aug 12, 2024 · The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tezepelumab-ekko for use as an add-on maintenance treatment in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype.
Dupixent Approved as Add-On Maintenance Therapy in COPD
Oct 1, 2024 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.. The approval was supported by data from the randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS (ClinicalTrials.gov Identifier ...
Hemorrhagic Pleural Effusion - Pulmonology Advisor
Nov 15, 2023 · Presentation and Cause. The pleural space, which is situated between the parietal and visceral pleura, typically has 7 to 16 ml of fluid. 1 Hemorrhagic pleural effusion occurs when excess fluid accumulates in this space due to fluid production exceeding the removal rate. There are many etiologies that can cause pleural effusion.
Nebulized Anticholinergic Therapy for Maintenance Treatment of …
For select patients with COPD, nebulized drugs might offer an alternative to a breath-actuated, hand-held inhaler. 5 Adherence to inhaled medication in patients with COPD is low, with the nonadherence rate ranging from 50% to 80%. 6 Among the causes of nonadherence is the inability to use an inhaler as directed. 6 Inhalers can be nearly impossible to use for patients who have a low inspiratory ...
A Low Forced Expiratory Flow of 25% to 75% May Indicate Early …
Dec 16, 2022 · Forced expiratory flow between 25% and 75% of vital capacity (FEF 25-75) is likely to identify patients with early evidence of pathologic lung damage in need of careful monitoring and early intervention to prevent additional lung injury, according to study findings published in BMJ Open Respiratory Research.. Traditional spirometric parameters — including forced expiratory volume in 1 second ...